questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines de transport
Protéines AAA
Protéines AAA : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Protéines AAA
Diagnostic médical
Protéines AAA
Tests de laboratoire
Marqueurs biologiques
Protéines AAA
Imagerie médicale
Protéines AAA
Symptômes
5
Troubles cognitifs
Protéines AAA
Symptômes cutanés
Protéines AAA
Douleurs musculaires
Protéines AAA
Variabilité des symptômes
Protéines AAA
Prévention
5
Éducation génétique
Protéines AAA
Habitudes alimentaires
Protéines AAA
Traitements
5
Traitements
Protéines AAA
Thérapie génique
Protéines AAA
Médicaments
Protéines AAA
Physiothérapie
Protéines AAA
Complications
5
Complications
Protéines AAA
Maladies cardiovasculaires
Protéines AAA
Troubles métaboliques
Protéines AAA
Réversibilité
Protéines AAA
Facteurs de risque
5
Facteurs de risque
Protéines AAA
Mode de vie
Protéines AAA
Vieillissement
Protéines AAA
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéines AAA : Questions médicales les plus fréquentes",
"headline": "Protéines AAA : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéines AAA : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-24",
"dateModified": "2025-02-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéines AAA"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines de transport",
"url": "https://questionsmedicales.fr/mesh/D002352",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de transport",
"code": {
"@type": "MedicalCode",
"code": "D002352",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "ATPases associated with diverse cellular activities",
"alternateName": "ATPases Associated with Diverse Cellular Activities",
"url": "https://questionsmedicales.fr/mesh/D000074183",
"about": {
"@type": "MedicalCondition",
"name": "ATPases associated with diverse cellular activities",
"code": {
"@type": "MedicalCode",
"code": "D000074183",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "ATP-dependent proteases",
"alternateName": "ATP-Dependent Proteases",
"url": "https://questionsmedicales.fr/mesh/D049069",
"about": {
"@type": "MedicalCondition",
"name": "ATP-dependent proteases",
"code": {
"@type": "MedicalCode",
"code": "D049069",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750.032"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "ATP-dependent endopeptidases",
"alternateName": "ATP-Dependent Endopeptidases",
"url": "https://questionsmedicales.fr/mesh/D057065",
"about": {
"@type": "MedicalCondition",
"name": "ATP-dependent endopeptidases",
"code": {
"@type": "MedicalCode",
"code": "D057065",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750.032.099"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protease La",
"alternateName": "Protease La",
"url": "https://questionsmedicales.fr/mesh/D049070",
"about": {
"@type": "MedicalCondition",
"name": "Protease La",
"code": {
"@type": "MedicalCode",
"code": "D049070",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750.032.099.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Protease La",
"alternateName": "Protease La",
"url": "https://questionsmedicales.fr/mesh/D049070",
"about": {
"@type": "MedicalCondition",
"name": "Protease La",
"code": {
"@type": "MedicalCode",
"code": "D049070",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750.032.099.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "ATP-dependent endopeptidases",
"alternateName": "ATP-Dependent Endopeptidases",
"url": "https://questionsmedicales.fr/mesh/D057065",
"about": {
"@type": "MedicalCondition",
"name": "ATP-dependent endopeptidases",
"code": {
"@type": "MedicalCode",
"code": "D057065",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750.032.099"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protease La",
"alternateName": "Protease La",
"url": "https://questionsmedicales.fr/mesh/D049070",
"about": {
"@type": "MedicalCondition",
"name": "Protease La",
"code": {
"@type": "MedicalCode",
"code": "D049070",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750.032.099.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Protease La",
"alternateName": "Protease La",
"url": "https://questionsmedicales.fr/mesh/D049070",
"about": {
"@type": "MedicalCondition",
"name": "Protease La",
"code": {
"@type": "MedicalCode",
"code": "D049070",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750.032.099.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "N-Ethylmaleimide-sensitive factors",
"alternateName": "N-Ethylmaleimide-Sensitive Proteins",
"url": "https://questionsmedicales.fr/mesh/D052066",
"about": {
"@type": "MedicalCondition",
"name": "N-Ethylmaleimide-sensitive factors",
"code": {
"@type": "MedicalCode",
"code": "D052066",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750.375"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Protéines AAA",
"alternateName": "AAA Proteins",
"code": {
"@type": "MedicalCode",
"code": "D000074582",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Tarun M Kapoor",
"url": "https://questionsmedicales.fr/author/Tarun%20M%20Kapoor",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Chemistry and Cell Biology, The Rockefeller University, New York, NY, USA. kapoor@rockefeller.edu."
}
},
{
"@type": "Person",
"name": "Tommaso Cupido",
"url": "https://questionsmedicales.fr/author/Tommaso%20Cupido",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Chemistry and Cell Biology, The Rockefeller University, New York, NY, USA."
}
},
{
"@type": "Person",
"name": "Rudolf Pisa",
"url": "https://questionsmedicales.fr/author/Rudolf%20Pisa",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Chemistry and Cell Biology, The Rockefeller University, New York, NY, USA."
}
},
{
"@type": "Person",
"name": "James Shorter",
"url": "https://questionsmedicales.fr/author/James%20Shorter",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, U.S.A."
}
},
{
"@type": "Person",
"name": "Robert T Sauer",
"url": "https://questionsmedicales.fr/author/Robert%20T%20Sauer",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Umbilical cord blood concentration of connecting peptide (C-peptide) and pregnancy outcomes.",
"datePublished": "2022-10-12",
"url": "https://questionsmedicales.fr/article/36224521",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12884-022-05081-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Impact of C-Peptide and Diabetes Mellitus on Coronary Ectasia and Effect of Coronary Ectasia and C-Peptide on Long-Term Outcomes: A Retrospective Cohort Study.",
"datePublished": "2022-10-08",
"url": "https://questionsmedicales.fr/article/36277470",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/7910566"
}
},
{
"@type": "ScholarlyArticle",
"name": "The association between a single abnormal glucose and fetal c-peptide.",
"datePublished": "2023-06-22",
"url": "https://questionsmedicales.fr/article/37347447",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00592-023-02123-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparability of C-Peptide Measurements - Current Status and Clinical Relevance.",
"datePublished": "2023-01-11",
"url": "https://questionsmedicales.fr/article/36630986",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-1998-6889"
}
},
{
"@type": "ScholarlyArticle",
"name": "A homogeneous enzyme-free ratiometric immunoassay for the determination of C-peptide.",
"datePublished": "2022-09-17",
"url": "https://questionsmedicales.fr/article/36126761",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ab.2022.114899"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines de transport",
"item": "https://questionsmedicales.fr/mesh/D002352"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines AAA",
"item": "https://questionsmedicales.fr/mesh/D000074582"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéines AAA - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéines AAA",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Protéines AAA",
"description": "Comment diagnostiquer une dysfonction des protéines AAA ?\nQuels tests sont utilisés pour évaluer les protéines AAA ?\nLes biopsies sont-elles utiles pour les protéines AAA ?\nQuels marqueurs biologiques sont associés aux protéines AAA ?\nLes imageries médicales aident-elles au diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D000074582?mesh_terms=C-Peptide#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Protéines AAA",
"description": "Quels symptômes indiquent une anomalie des protéines AAA ?\nLes troubles cognitifs sont-ils liés aux protéines AAA ?\nY a-t-il des symptômes cutanés associés ?\nLes douleurs musculaires sont-elles fréquentes ?\nLes symptômes varient-ils selon les types de protéines AAA ?",
"url": "https://questionsmedicales.fr/mesh/D000074582?mesh_terms=C-Peptide#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Protéines AAA",
"description": "Peut-on prévenir les dysfonctionnements des protéines AAA ?\nLes dépistages réguliers sont-ils utiles ?\nL'éducation génétique est-elle importante ?\nLes habitudes alimentaires influencent-elles la santé des protéines ?\nLe stress a-t-il un impact sur les protéines AAA ?",
"url": "https://questionsmedicales.fr/mesh/D000074582?mesh_terms=C-Peptide#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Protéines AAA",
"description": "Quels traitements existent pour les dysfonctionnements des protéines AAA ?\nLa thérapie génique est-elle efficace ?\nDes médicaments spécifiques sont-ils disponibles ?\nLes approches nutritionnelles aident-elles ?\nLa physiothérapie est-elle recommandée ?",
"url": "https://questionsmedicales.fr/mesh/D000074582?mesh_terms=C-Peptide#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Protéines AAA",
"description": "Quelles complications peuvent survenir avec les protéines AAA ?\nLes maladies cardiovasculaires sont-elles liées ?\nY a-t-il des risques de cancer associés ?\nLes troubles métaboliques sont-ils possibles ?\nLes complications sont-elles réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D000074582?mesh_terms=C-Peptide#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Protéines AAA",
"description": "Quels sont les facteurs de risque pour les dysfonctionnements des protéines AAA ?\nL'hérédité joue-t-elle un rôle ?\nLe mode de vie influence-t-il le risque ?\nLes infections peuvent-elles affecter les protéines AAA ?\nLe vieillissement est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D000074582?mesh_terms=C-Peptide#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction des protéines AAA ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests génétiques et des analyses protéomiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les protéines AAA ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de fonction cellulaire et des dosages d'ATPase peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles utiles pour les protéines AAA ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les biopsies peuvent aider à évaluer l'expression des protéines AAA dans les tissus."
}
},
{
"@type": "Question",
"name": "Quels marqueurs biologiques sont associés aux protéines AAA ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs comme Hsp70 peuvent être utilisés pour évaluer l'activité des protéines AAA."
}
},
{
"@type": "Question",
"name": "Les imageries médicales aident-elles au diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie peut montrer des anomalies cellulaires, mais n'est pas spécifique aux protéines AAA."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une anomalie des protéines AAA ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes incluent la faiblesse musculaire, la fatigue et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les troubles cognitifs sont-ils liés aux protéines AAA ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies peuvent entraîner des troubles cognitifs et de la mémoire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies liées aux protéines AAA peuvent provoquer des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Les douleurs musculaires sont-elles fréquentes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs musculaires peuvent survenir en raison de dysfonctionnements des protéines."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les types de protéines AAA ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon le type de protéine AAA impliquée et la pathologie."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les dysfonctionnements des protéines AAA ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un mode de vie sain peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Les dépistages réguliers sont-ils utiles ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dépistages peuvent aider à identifier précocement les anomalies génétiques."
}
},
{
"@type": "Question",
"name": "L'éducation génétique est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation sur les maladies héréditaires peut aider à la prévention."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles la santé des protéines ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir la santé cellulaire et protéique."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les protéines AAA ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affecter la fonction cellulaire et les protéines."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les dysfonctionnements des protéines AAA ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des thérapies géniques et des médicaments ciblant les voies cellulaires."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle efficace ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie génique montre des résultats prometteurs dans certaines pathologies liées."
}
},
{
"@type": "Question",
"name": "Des médicaments spécifiques sont-ils disponibles ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs de l'ATPase sont en cours d'étude pour traiter les dysfonctionnements."
}
},
{
"@type": "Question",
"name": "Les approches nutritionnelles aident-elles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une nutrition adéquate peut soutenir la fonction cellulaire, mais n'est pas un traitement direct."
}
},
{
"@type": "Question",
"name": "La physiothérapie est-elle recommandée ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la physiothérapie peut aider à gérer les symptômes musculaires et améliorer la fonction."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les protéines AAA ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des maladies neurodégénératives et des troubles musculaires."
}
},
{
"@type": "Question",
"name": "Les maladies cardiovasculaires sont-elles liées ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines dysfonctionnements des protéines AAA peuvent augmenter le risque cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de cancer associés ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies dans les protéines AAA peuvent être liées à certains types de cancer."
}
},
{
"@type": "Question",
"name": "Les troubles métaboliques sont-ils possibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dysfonctionnements peuvent entraîner des troubles métaboliques variés."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être irréversibles."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les dysfonctionnements des protéines AAA ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des prédispositions génétiques, l'âge et des facteurs environnementaux."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines mutations génétiques héréditaires augmentent le risque de dysfonction."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles affecter les protéines AAA ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales peuvent perturber la fonction des protéines AAA."
}
},
{
"@type": "Question",
"name": "Le vieillissement est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut affecter la fonction des protéines et augmenter les risques."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 18/02/2025
Contenu vérifié selon les dernières recommandations médicales
6 publications dans cette catégorie
Affiliations :
Laboratory of Chemistry and Cell Biology, The Rockefeller University, New York, NY, USA. kapoor@rockefeller.edu.
4 publications dans cette catégorie
Affiliations :
Laboratory of Chemistry and Cell Biology, The Rockefeller University, New York, NY, USA.
Publications dans "Protéines AAA" :
4 publications dans cette catégorie
Affiliations :
Laboratory of Chemistry and Cell Biology, The Rockefeller University, New York, NY, USA.
Tri-Institutional PhD Program in Chemical Biology, The Rockefeller University, New York, NY, USA.
Publications dans "Protéines AAA" :
3 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, U.S.A.
Publications dans "Protéines AAA" :
3 publications dans cette catégorie
Publications dans "Protéines AAA" :
3 publications dans cette catégorie
Publications dans "Protéines AAA" :
3 publications dans cette catégorie
Affiliations :
Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. xiad@mail.nih.gov.
Publications dans "Protéines AAA" :
3 publications dans cette catégorie
Publications dans "Protéines AAA" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Chemistry and Cell Biology, The Rockefeller University, New York, NY, USA.
Tri-Institutional PhD Program in Chemical Biology, The Rockefeller University, New York, NY, USA.
Publications dans "Protéines AAA" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, U.S.A.
Publications dans "Protéines AAA" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of Alabama at Birmingham, Birmingham, AL, U.S.A.
Publications dans "Protéines AAA" :
2 publications dans cette catégorie
Publications dans "Protéines AAA" :
2 publications dans cette catégorie
Publications dans "Protéines AAA" :
2 publications dans cette catégorie
Publications dans "Protéines AAA" :
2 publications dans cette catégorie
Publications dans "Protéines AAA" :
2 publications dans cette catégorie
Publications dans "Protéines AAA" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Chemistry and Cell Biology, The Rockefeller University, New York, NY 10065, USA; Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program, New York, NY 10065, USA.
Publications dans "Protéines AAA" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of Cincinnati, Cincinnati, OH 45221, USA.
Publications dans "Protéines AAA" :
2 publications dans cette catégorie
Affiliations :
Department of Chemical and Biological Physics, Weizmann Institute of Science, Rehovot 761001, Israel.
Publications dans "Protéines AAA" :
2 publications dans cette catégorie
Affiliations :
Department of Chemical and Biological Physics, Weizmann Institute of Science, Rehovot 761001, Israel.
Publications dans "Protéines AAA" :
C-peptide offers potential as a marker to indicate childhood metabolic outcomes. Measuring C-peptide concentration might have better future utility in the risk stratification of neonates born to overw...
For the present study, 858 pregnant women were randomly selected from among a sub-group of 35,430 Iranian pregnant women who participated in a randomized community non-inferiority trial of gestational...
In the univariate model, positive GDM status was associated with a 0.3 (95% CI: 0.06 - 0.54, p = 0.01) increase in the median coefficient of UC blood C-peptide concentration. Moreover, one unit (kg) i...
UC blood concentration of C-peptide is significantly associated with the incidence of maternal GDM and neonatal macrosomia. Using stratification for maternal BMI and gestational weight gain (GWG) and ...
Coronary artery ectasia (CAE) is an entity frequently associated with atherosclerotic coronary artery disease (CAD) in clinical practice. Although it has common risk factors with atherosclerotic CAD i...
A total of 6611 patients who underwent coronary angiography were followed up retrospectively, and their major adverse cardiovascular event (MACE) status of an average of sixty months was recorded. Acc...
A total of 552 patients had CAE and MACE developed in 573 patients. Patients with CAE and higher C-peptide levels (Q4 + Q3) showed higher rates of MACE as compared to those without CAE and lower C-pep...
Our study revealed that a high C-peptide level is an independent risk factor for CAE and that CAE and C-peptide are independent predictors for the development of MACE....
We aimed to evaluated if fetuses of subjects with one elevated value on the 3-h GTT had a measurable physiologic difference in fetal C-peptide levels as compared to those with no elevated values on th...
We performed a prospective cohort study to evaluate insulin levels in singleton non-anomalous fetuses of subjects with one elevated value on the GTT as compared to subjects with no elevated values on ...
Our analysis included 99 subjects, with 49 subjects in the one elevated value group and 50 subjects in the no elevated values group. Fetal C-peptide levels (picomoles per liters, pmol/L), were signifi...
Fetuses of subjects who had one elevated value on their GTT had a measurable physiologic difference in C-peptide levels as compared to fetuses of subjects with no elevated values on the GTT....
C-peptide is an increasingly used and established marker for beta cell function by assessing endogenous insulin secretion. Accurate and comparable C-peptide measurements are needed in clinical practic...
In this study, a homogeneous enzyme-free ratiometric (HOMO- EF-RA) immunoassay was developed for the sensitive detection of C-peptide. In the immunoassay, there have been a miscible detection system b...
Relative telomere length (RTL) predicts the development of many age-related diseases. Yet, few studies have evaluated their longitudinal effect on RTL. We investigated longitudinally the association b...
This was a longitudinal study with a 5-year follow-up period, based on data collected in 2014 and 2019. Of 478 participants in 2014, 198 consented to be followed-up in 2019. The associations between R...
RTL was significantly shortened after 5 years (P<0.001). Older age (P=0.018) and gender (P=0.05) were significantly associated with shorter RTL at follow-up. Higher baseline C-peptide correlated with ...
Higher C-peptide level contributes to telomere shortening over time, suggesting that metabolic dysregulation may play a role in early aging. Further understanding of this relationship and addressing h...
Cephalic phase insulin release (CPIR) is a rapid pulse of insulin secreted within minutes of food-related sensory stimulation. Understanding the mechanisms underlying CPIR in humans has been hindered ...
Impaired beta-cell function is a recognized cornerstone of diabetes pathophysiology. Estimates of insulin secretory capacity are useful to inform clinical practice, helping to classify types of diabet...
To find suitable external quality assessment (EQA) materials for serum C-peptide, we evaluated the commutability of five types of processed materials....
Seventy-four individual serum samples and 12 processed samples including three EQA samples currently in use, frozen human serum pools (FHSP), and three other kinds of processed samples were prepared b...
Out of the five kinds of processed materials, FHSP samples were commutable on most assays. In contrast, the EQA materials currently in use were only commutable on a few immunoassays. Additionally, pro...
With clarified commutability and stability information, the human serum pool samples along with the developed ID-LC-MS/MS method could be used in the EQA program to promote the comparability among lab...
C-peptide levels are a key measure of beta-cell mass following islet transplantation, but threshold values required to achieve clinically relevant patient-centered outcomes are not yet established....
We conducted a cross-sectional retrospective cohort study evaluating patients undergoing islet transplantation at a single center from 1999 to 2018. Cohorts included patients achieving insulin indepen...
We analyzed 192 patients, with 122 (63.5%) being insulin independent without hypoglycemia, 61 (31.8%) being insulin dependent without hypoglycemia, and 9 (4.7%) experiencing recurrent symptomatic hypo...
We define C-peptide levels and BETA-2 scores associated with patient-centered outcomes. Characterizing these values will enable evaluation of ongoing clinical trials with islet or stem cell therapies....